Navigation Links
Can engineered bugs help generate biofuels? Study holds promise
Date:12/1/2010

Montreal December 1, 2010 The versatile organism Lactococcus lactis, the workhorse bacterium that helps turn milk into cheese, may also be valuable in the understanding of how microbes turn the organic compound cellulose into biofuels.

New research from Concordia University, published in the journal Microbial Cell Factories, suggests the bacterium can be engineered to transform plant material into biofuels or other chemicals.

Concordia biology professor Vincent Martin and his PhD student Andrew Wieczorek demonstrated how structural or scaffolding proteins on the surface of the bacteria can be engineered in Lactococcus lactis towards the breakdown of plant material.

They showed how these scaffold proteins were successful in providing a stable surface outside the cell for chemical activity, e.g. the transformation of plant material into biofuels.

"This is the first study to show how the scaffolding proteins, can be secreted and localized to the cell surface of Lactococcus," says Dr. Martin, who is also Canada Research Chair in Microbial Genomics and Engineering.

"Exporting these proteins and localizing them to the outside of the cell is a huge milestone. This can enhance the efficiency of any bioprocesses or the breakdown of organic materials."

What's promising about this research, stresses Professor Martin, is how the scaffolding proteins of Lactococcus lactis appear to bond with multiple compounds. "Our next step will be to engineer larger more complex scaffolds that can encourage other bio-processes that can eventually enhance the yield of fuels in a manner that is commercially viable."


'/>"/>

Contact: Sylvain-Jacques Desjardins
s-j.desjardins@concordia.ca
51-484-824-245-068
Concordia University
Source:Eurekalert

Page: 1

Related biology news :

1. Engineered pig stem cells bridge the mouse-human gap
2. Genetically engineered mice yield clues to knocking out cancer
3. First genetically-engineered malaria vaccine to enter human trials
4. Engineered tobacco plants have more potential as a biofuel
5. Bioengineered materials promote the growth of functional vasculature, new study shows
6. Genetically engineered tobacco plant cleans up environmental toxin
7. Genetically engineered crops benefit many farmers, but the technology needs proper management to remain effective
8. Native-like spider silk produced in metabolically engineered bacterium
9. Engineered coral pigment helps scientists to observe protein movement
10. Most complete beer proteome finding could lead to engineered brews
11. Engineered plants make potential precursor to raw material for plastics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: